Both in Pharmaceuticals
Pacira BioSciences vs Janux Therapeutics
Over the past year PCRX returned +1.2% and JANX returned −28.5%; their daily moves had a correlation of 0.07.
PCRX +1.2% JANX −28.5%Growth of $1, one year, split-adjusted
| Metric | PCRX | JANX |
|---|---|---|
| Price | $25.65 | $16.95 |
| Market cap | $1.02B | $1.04B |
| Today | +1.02% | +2.23% |
| 1 month | −0.4% | −6.0% |
| 6 months | +10.2% | +30.1% |
| Year to date | −0.9% | +22.8% |
| 1 year | +1.6% | −27.0% |
| Revenue growth (YoY) | +6.2% | — |
| Gross margin | 77.0% | 100.0% |
| Net margin | 2.4% | −214.0% |
| P/E (TTM) | 69.8× | — |
| Price / sales | 1.4× | 43.2× |
| Net cash | -$112.1M | $970.9M |
| Dividend yield | — | — |
| Volatility (60d) | 35.7% | 46.4% |
| Short % of float | 20.1% | 13.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).